Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22 for the treatment of r/r B-cell ALL
The first patient completed the 28-day Dose Limiting Toxicity (DLT) observation period without complication NEW…
Atha Energy Makes Major New High-Grade Discovery along the Lac 50 Corridor – Intersects 11.5 m of Composite Uranium Mineralization Including 1.6 m of Near Continuous High-Grade 4 km Along Strike from Lac 50 Deposit Area
3DG Holdings Announces Opening of First ‘Ultimate Luxury Shop’ in Hong Kong at YOHO Mall
China-France Cultural Dialogue Highlights Research on the Overseas Dissemination of Xi Jinping: The Governance of China V
GMG Board Approves Capital for Engineering of Factory for Graphene Factories
Phoenitron Enters Intelligent Fire Protection Sector via CyberMirage’s Strategic Cooperation Framework Agreement